PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
Prospective, non-randomized, multicenter clinical investigation to assess the safety and
effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with
evidence of malperfusion, through open surgical repair.
Age: 18 - 80 years
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry will be used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an arte...
Age: Birth - 120 years
Gender: All
Post-Approval Study of the TREO Abdominal Stent-Graft System
The purpose of this study is to determine the long-term performance of the TREO Abdominal
Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or
Aorto-iliac Aneurysms.
Age: 18 years - 66+
Gender: All
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry,
is to serve as an internationally collaborative, multicenter registry coordinated by an
experienced and centralized coordinating center in an effort to increase the pace of...
Age: 18 years - 66+
Gender: All
Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
The primary objective of this study is to evaluate the safety and effectiveness of the
Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial
aneurysms measuring ≤ 12 mm and located on the ICA or its branches
Age: 18 - 80 years
Gender: All
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Prospective, non-randomized, , multicenter study with two independent arms: - Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. - Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis...
Age: 19 years - 66+
Gender: All
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Prospective, non-randomized, , multicenter study with two independent arms:
- Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System.
Hypothesis-driven analysis.
- Up to 40 additional subjects may be implanted in Continued Access Phase un...
Age: 19 years - 66+
Gender: All
A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and
GALAXY coils
Age: 21 - 80 years
Gender: All
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
The ascending aorta conducts blood from the heart to the rest of the body. The ascending
aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger
aorta. When the ascending aorta tears or ruptures, the risk dying is high even if sur...
Age: 18 - 79 years
Gender: All
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
The ascending aorta conducts blood from the heart to the rest of the body. The ascending
aorta can become enlarged, and the risk of tearing and rupturing becomes higher with larger
aorta. When the ascending aorta tears or ruptures, the risk dying is high even if sur...
Age: 18 - 79 years
Gender: All
Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device
The purpose of this study is to demonstrate effectiveness and safety of the CODMAN
ENTERPRISE® Vascular Reconstruction Device and Delivery System.
Age: 21 - 70 years
Gender: All
Defining the Basis of Fibromuscular Dysplasia (FMD)
The purpose of this study has evolved and expanded since its inception. Originally the intent
was to establish the functional, molecular and genetic profile of fibroblasts from
Fibromuscular Dysplasia (FMD) patients as compared to carefully matched control subjects....
Age: 18 years - 66+
Gender: All